Subcutaneous Biologics Market Poised for 11% CAGR Growth Through 2030

Global Subcutaneous Biologics Market: Key Dynamics, Size & Share Analysis

As per MarkNtel Advisors the Global Subcutaneous Biologics Market size was valued at around USD 2.02 billion in 2024 and is projected to reach USD 4.11 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11% during the forecast period, i.e., 2025-30.

Global Subcutaneous Biologics Market Drivers:

Growing Prevalence of Chronic Diseases – The ubiquity of chronic diseases is a major factor driving the market demand. These diseases are increasing rapidly due to the rise in the elderly population globally. By 2050, the elderly population will grow to around 2 billion, which was just 900 million in 2015. They are more prone to chronic & cardiovascular diseases that require long-term care with important medications like biologics. Around 800 million people are suffering from diabetes globally, with numbers growing over the years. Also, over 360 million people around the world are affected by arthritis. This creates the need for biologics to provide ease in treatment for both patients & doctors. Globally, over 20 million new cancer diagnoses happen annually, as per the American Cancer Society. With cancer treatment plans increasingly individualized, subcutaneous biologics are predicted to be used more regularly due to their benefits of fewer health center visits and improved patient compliance.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Explore the Insights – Download a Free Sample: https://www.marknteladvisors.com/query/request-sample/subcutaneous-biologics-market.html

Subcutaneous Biologics Market Systems Market Segmentation:

-By Subcutaneous Drug Delivery System

Prefilled Syringe - Market Size & Forecast 2020-2030, (USD Million)
Wearable Injectors - Market Size & Forecast 2020-2030, (USD Million)
Auto-Injectors - Market Size & Forecast 2020-2030, (USD Million)
Implants - Market Size & Forecast 2020-2030, (USD Million)
Pen Injectors - Market Size & Forecast 2020-2030, (USD Million)
Drug Reconstitution Delivery Systems - Market Size & Forecast 2020-2030, (USD Million)

-By Application

Crohn’s Disease - Market Size & Forecast 2020-2030, (USD Million)
Rheumatoid Arthritis - Market Size & Forecast 2020-2030, (USD Million)
Cancer - Market Size & Forecast 2020-2030, (USD Million)
Leukaemia - Market Size & Forecast 2020-2030, (USD Million)
Lymphoma - Market Size & Forecast 2020-2030, (USD Million)
Psoriasis - Market Size & Forecast 2020-2030, (USD Million)
Diabetes - Market Size & Forecast 2020-2030, (USD Million)
Cardiovascular Disorder - Market Size & Forecast 2020-2030, (USD Million)
Others - Market Size & Forecast 2020-2030, (USD Million)

-By Distribution Channel

Hospital Pharmacy - Market Size & Forecast 2020-2030, (USD Million)
Retail Pharmacy - Market Size & Forecast 2020-2030, (USD Million)
Online Pharmacy - Market Size & Forecast 2020-2030, (USD Million)
Others - Market Size & Forecast 2020-2030, (USD Million)

Geographical Analysis of the Subcutaneous Biologics Market

-By Region

North America
South America
Europe
The Middle East and Africa
Asia-Pacific

Due to its developed healthcare network and high rate of diseases, North America now has the majority market share in the subcutaneous biologics market all over the world. This region holds about 38% of the entire global market. The status of prominent industry players such as Pfizer, Roche, and Amgen in the region contributes to its dominance.

Tap into future trends and opportunities shaping the Subcutaneous Biologics view the complete report: https://www.marknteladvisors.com/research-library/subcutaneous-biologics-market.html

Subcutaneous Biologics Market Recent Development:

August 2024: Novartis partnered with Lindy Biosciences to develop high-concentration subcutaneous biologic injectables using microglassification technology, enhancing treatment convenience and improving patient compliance in the global biologics market.
May 2024: Biogen and Eisai submitted a rolling FDA application for a subcutaneous version of Leqembi, an Alzheimer’s drug, which may reduce hospital visits and nursing care, offering a more convenient treatment option.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Report Highlights Essential Insights for Strategic Decision-Making

Detailed market size, share, and forecast analysis
In-depth pricing trends and segment-wise cost evaluations
Key industry strategies, including innovation, partnerships, and acquisitions
Critical value chain analysis and stakeholder profiling
Regional import-export market insights and trade flow assessment
Thorough competitive benchmarking of top hearing aid manufacturers
Identification of new growth opportunities and niche market segments
Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the Subcutaneous Biologics Market are:

AbbVie, Inc.
Hoffmann-La
Biogen Idec
Amgen, Inc.,
Pfizer Ltd.
Marcolin SpA
Bristol-Myers Squibb
Takeda Pharmaceutical Company Ltd.
Roche AG
Genentech Inc.
Eisai, Inc.
Novartis AG
Bayer AG
Abbott Laboratories
GlaxoSmithKline
Others

Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/subcutaneous-biologics-market.html

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Key Steps:

Define objectives and research design
Collect data through surveys and interviews
Analyze and validate data using reliable tools
Forecast trends and deliver actionable insights

About us:

MarkNtel Advisors is a distinguished Industry Research Report Firm and Market Research Company offering comprehensive intelligence across the healthcare sector, covering pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our team delivers high-precision Market Research Reports and Business Analysis at global, regional, and country levels to help organizations understand market access strategies, innovation trends, and regulatory frameworks. Using robust data methodologies and validated Market Forecast models, we provide insights that enhance decision-making and operational agility. Our expertise extends to Customized Market Research Reports that measure therapeutic performance, digital transformation, and patient-centric solutions. Through strategic Consulting Services, we empower healthcare companies, investors, and policymakers to quantify Revenue Impact, strengthen competitiveness, and accelerate sustainable growth within the dynamic global healthcare landscape.